The Future of CLL Treatment: What’s Next?
June 18, 2024
Topics Covered
We invite you to learn more about:
- Watch and wait (active monitoring) for chronic lymphocytic leukemia (CLL)
- New and emerging therapies for CLL
- Side-effect management
- Late effects of treatment
- Shared decision-making with your treatment team
Program Materials
Speaker
Adam S Kittai, MD
Hematologist/Oncologist
Associate Professor
Assistant Director, Lymphoma Clinical Research
Leader, CLL Clinical Research
Icahn School of Medicine at Mount Sinai
New York, NY
Program Support
Support for this program provided by AbbVie Inc., BeiGene USA, Inc., Genentech, Inc. & Biogen, and Lilly.